MHE Question of the Week

News
Article
Pages: 1

Should site-neutral payment rules and policies be extended to commercial payers, payment for physician-administered drugs, and services delivered in on-campus hospital outpatient departments?

We want to know what you’re thinking! Every Tuesday morning, the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We'll tally your answers and publish the results on Friday by 4 p.m. ET.

Some background on this week’s question

Payment for outpatient services has traditionally varied depending on where the services were delivered. Typically, they have been higher at hospital outpatient facilities than at physician offices. But as hospitals have bought physician practices and expanded their outpatient facilities, payers and others have pushed for “site-neutral” payment that pays the same amount for the service, regardless of where it is delivered. Medicare already has some site-neutral payment policies.

Now Congress and regulators are considering legislation and rules that would extend site-neutral payment further to include physician-administered drugs and outpatient facilities located on hospital campuses. Some proposals would also apply site-neutral payment rules to commercial payers.

Hospitals and some other groups are fighting site-neutral payment, arguing that patients seen in hospital facilities receive more coordinated care and are often more medically complex.

Should site-neutral payment rules and policies be extended to commercial payers, payment for physician-administered drugs, and services delivered in on-campus hospital outpatient departments?

Yes
No

Recent Videos
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 4 - "The Impact of Continuous Glucose Monitors & Digital Solutions on Diabetes Care"
Video 3 - "The Pivotal Role of Patient Engagement and Education in Achieving Optimal Diabetes Outcomes"
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Related Content
© 2024 MJH Life Sciences

All rights reserved.